Search results for "wt"

showing 10 items of 5424 documents

Lipoprotein alterations and reduced growth hormone secretion: relationships with obesity and cardiovascular risk1

2012

medicine.medical_specialtyEndocrinologyEndocrinologybusiness.industryEndocrinology Diabetes and MetabolismInternal medicinemedicinemedicine.diseasebusinessObesityGrowth hormone secretionLipoproteinClinical Endocrinology
researchProduct

Hepatocyte growth factor induces a protective effect in cerulein-induced acute pancreatitis in mice

2016

medicine.medical_specialtyEndocrinologyHepatologybusiness.industryEndocrinology Diabetes and MetabolismInternal medicineGastroenterologymedicineAcute pancreatitisHepatocyte growth factormedicine.diseasebusinessmedicine.drugPancreatology
researchProduct

PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars: The Case of Epoetine, Granulocyte-Colony Stimulating Factor, a…

2012

medicine.medical_specialtyEndocrinologyInternal medicineHealth PolicymedicinePublic Health Environmental and Occupational HealthBiosimilarBiologyGrowth hormoneGranulocyte colony-stimulating factorMarket penetrationValue in Health
researchProduct

Author response: Mutations in SKI in Shprintzen–Goldberg syndrome lead to attenuated TGF-β responses through SKI stabilization

2020

medicine.medical_specialtyEndocrinologybusiness.industryInternal medicineMedicineShprintzen–Goldberg syndromebusinessmedicine.diseaseTransforming growth factor
researchProduct

NAM Therapy-Evidence-Based Results

2020

Many orthodontists working on patients with cleft lip and palate (CLP) have shown great enthusiasm for presurgical infant orthopedics (PSIO) to improve surgical outcomes with minimal intervention. Even though every clinician aims to use the best treatment modality for their patients, PSIO effects can be confounded by surgical type and timing of the primary repair, as is discussed in many studies. In such cases, one should be cautious when evaluating the particular outcomes for patients with CLP since it is difficult to differentiate the sole effect of an individual surgical or orthodontic intervention. As with any treatment methodology, nasoalveolar molding (NAM) has both benefits and limi…

medicine.medical_specialtyEvidence-based practiceinfant orthopedicmedicine.medical_treatmentCleft Lipmidfacial growthNoseBurden of care03 medical and health sciencesPrimary repair0302 clinical medicineIntervention (counseling)medicineDeformityMaxillaHumansOrthopedic Procedures030223 otorhinolaryngologyIntensive care medicineMaxillary growthReduction (orthopedic surgery)business.industryInfant orthopedicsInfant030206 dentistryPlastic Surgery ProceduresCleft PalateOtorhinolaryngologyfacial growthOral Surgerymedicine.symptombusinessnonsyndromic clefting
researchProduct

Postnatal weight change is influenced by mother-newborn pair leptin levels

2000

We investigated serum leptin levels in 103 mother-newborn-pairs; Cord leptin was significantly higher than mother's leptin (5.7 ± 5.5 vs. 22.1 ± 19.9 ng/ml; p <0.001). Cord leptin was significantly higher in females than males (6.9 ± 6.3 vs. 3.9 ± 3.6 ng/ml respectively; p <0.001), and correlated with maternal leptin (r = 0.24; p = 0.001), gestational age (r = 0.54; p <0.001), and birth weight (r = 0.56; p <0.001). Neonatal leptin at the 4(th) day significantly correlated with percent weight loss in the first four days of life. These observations shed light on the origin of cord leptin and on the role of leptin in postnatal weight loss. (C) 2000 Elsevier Science Inc.

medicine.medical_specialtyFetusNutrition and DieteticsCordEndocrinology Diabetes and MetabolismBirth weightLeptindigestive oral and skin physiologyWeight changePeptide hormoneBiologyCord leptin levelEndocrinologyEndocrinologyNeonatal growth factorWeight lossCord bloodInternal medicinemedicinePostnatal weight loss.medicine.symptomhormones hormone substitutes and hormone antagonistsNutrition Research
researchProduct

Prosthetic strap system for simplified ventral hernia repair. Its results in a porcine experimental model.

2010

Abstract: Introduction Aiming to achieve a simplified ventral hernia repair, a proprietary shaped mesh was experimentally tested in the porcine model. The mesh is structured with a large central body and radiating straps. The friction of the straps passing through the tissues are hypothesized to be adequate to maintain the mesh in place during tissue ingrowth, avoiding classic point fixation while ensuring a wide coverage of the abdomen. Methods The mesh, having 6 radial straps, was placed using a sublay preperitoneal technique in 4 pigs. All straps were passed laterally through the abdominal wall and exteriorized from the skin. The straps were trimmed at the level of the skin, allowing the…

medicine.medical_specialtyFrictionSwineProsthesis ImplantationFixation (surgical)Ventral hernia; Prostheses and implants; Incorporation;Surgical fixation devices; FrictionmedicineAnimalsHerniaIncorporationProstheses and implantWound HealingSurgical fixation deviceVentral hernia repairExperimental modelSurgical Fixation Devicebusiness.industryAnatomySurgical Meshmedicine.diseaseHernia VentralSurgerybody regionsSettore MED/18 - Chirurgia GeneraleSurgical meshVentral herniaVentral herniaModels AnimalFeasibility StudiesSurgerybusinessTissue ingrowth
researchProduct

Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2

2012

Tumor vessel dysfunction is a pivotal event in cancer progression. Using an in vivo neovascularization model, we identified G protein–coupled receptor kinase 2 (GRK2) as a key angiogenesis regulator. An impaired angiogenic response involving immature vessels was observed in mice hemizygous for Grk2 or in animals with endothelium-specific Grk2 silencing. ECs isolated from these animals displayed intrinsic alterations in migration, TGF-β signaling, and formation of tubular networks. Remarkably, an altered pattern of vessel growth and maturation was detected in postnatal retinas from endothelium-specific Grk2 knockout animals. Mouse embryos with systemic or endothelium-selective Grk2 ablation …

medicine.medical_specialtyG-Protein-Coupled Receptor Kinase 2Angiogenic SwitchAngiogenesisMedicinaActivin Receptors Type IIMelanoma ExperimentalReceptor Transforming Growth Factor-beta Type INeovascularization PhysiologicProtein Serine-Threonine KinasesBiologyMural cellGrk2Transforming Growth Factor beta1NeovascularizationMiceDownregulation and upregulationCell MovementPregnancyInternal medicinemedicineAnimalsHumansCell ProliferationHemizygoteMice KnockoutG protein-coupled receptor kinaseTumorNeovascularization PathologicEndothelial CellsRetinal VesselsG proteinGeneral MedicineCell biologyEndocrinologymedicine.anatomical_structurecardiovascular systemFemalePericyteSignal transductionmedicine.symptomActivin Receptors Type IReceptors Transforming Growth Factor betaSignal TransductionResearch Article
researchProduct

Neuroprotective Actions of Estradiol and Novel Estrogen Analogs in Ischemia: Translational Implications

2010

This review highlights our investigations into the neuroprotective efficacy of estradiol and other estrogenic agents in a clinically relevant animal model of transient global ischemia, which causes selective, delayed death of hippocampal CA1 neurons and associated cognitive deficits. We find that estradiol rescues a significant number of CA1 pyramidal neurons that would otherwise die in response to global ischemia, and this is true when hormone is provided as a long-term pretreatment at physiological doses or as an acute treatment at the time of reperfusion. In addition to enhancing neuronal survival, both forms of estradiol treatment induce measurable cognitive benefit in young animals. Mo…

medicine.medical_specialtyGPR30hippocampusIschemiaEstrogen receptorHippocampusNeuroprotectionArticleEstradiol CongenersIschemiaInternal medicineestradiolmedicineAnimalsHumansEndocrine and Autonomic Systemsbusiness.industryCREBEstrogen analogapoptosismedicine.diseasestrokeglobal ischemiainsulin-like growth factor-1EndocrinologyNeuroprotective AgentsneuroprotectionEstradiol CongenersbusinessGPERhormones hormone substitutes and hormone antagonistsHormoneestrogen receptor
researchProduct

Diacylglycerol kinase α mediatses 17-β-estradiol-induced proliferation, motility, and anchorage-independent growth of Hec-1A endometrial cancer cell …

2011

Increased levels of endogenous and/or exogenous estrogens are one of the well known risk factors of endometrial cancer. Diacylglycerol kinases (DGKs) are a family of enzymes which phosphorylate diacylglycerol (DAG) to produce phosphatidic acid (PA), thus turning off and on DAG-mediated and PA-mediated signaling pathways, respectively. DGK α activity is stimulated by growth factors and oncogenes and is required for chemotactic, proliferative, and angiogenic signaling in vitro. Herein, using either specific siRNAs or the pharmacological inhibitor R59949, we demonstrate that DGK α activity is required for 17-β-estradiol (E2)-induced proliferation, motility, and anchorage-independent growth of …

medicine.medical_specialtyGPR30medicine.drug_classCell SurvivalDiacylglycerol kinaseMotilityEstrogen receptorEnzyme AssayEndometrial carcinomaBiologyQuinazolinoneReceptors G-Protein-CoupledPiperidinePiperidinesCell MovementInternal medicineCell Line TumormedicineCell AdhesionHumansEndometrial NeoplasmEnzyme AssaysQuinazolinonesDiacylglycerol kinaseCell ProliferationEstradiolCell growthKinaseCell BiologyDiacylglycerol kinase; Endometrial carcinoma; Estrogen; GPR30; Cell BiologyEstrogenEndometrial NeoplasmsCell biologyEnzyme ActivationLipoprotein LipaseEndocrinologyReceptors EstrogenEstrogenGene Knockdown TechniquesGene Knockdown TechniqueFemaleRNA InterferenceSignal transductionGPERHuman
researchProduct